Squarepoint’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Buy |
199,649
+123,938
| +164% | +$1.01M | ﹤0.01% | 1258 |
|
|
2025
Q1 | $594K | Buy |
+75,711
| New | +$594K | ﹤0.01% | 1807 |
|
|
2024
Q3 | – | Sell |
-16,700
| Closed | -$254K | – | 2943 |
|
|
2024
Q2 | $254K | Buy |
+16,700
| New | +$254K | ﹤0.01% | 2035 |
|
|
2024
Q1 | – | Sell |
-32,569
| Closed | -$622K | – | 2832 |
|
|
2023
Q4 | $622K | Sell |
32,569
-214,211
| -87% | -$4.09M | ﹤0.01% | 1579 |
|
|
2023
Q3 | $4.43M | Sell |
246,780
-27,668
| -10% | -$497K | 0.01% | 648 |
|
|
2023
Q2 | $5.57M | Buy |
274,448
+186,862
| +213% | +$3.8M | 0.02% | 536 |
|
|
2023
Q1 | $1.6M | Buy |
87,586
+53,961
| +160% | +$984K | 0.01% | 937 |
|
|
2022
Q4 | $695K | Buy |
33,625
+17,527
| +109% | +$362K | ﹤0.01% | 1293 |
|
|
2022
Q3 | $421K | Sell |
16,098
-88,417
| -85% | -$2.31M | ﹤0.01% | 1462 |
|
|
2022
Q2 | $2.65M | Buy |
104,515
+2,819
| +3% | +$71.4K | 0.01% | 651 |
|
|
2022
Q1 | $3.21M | Buy |
101,696
+84,281
| +484% | +$2.66M | 0.01% | 609 |
|
|
2021
Q4 | $705K | Buy |
+17,415
| New | +$705K | ﹤0.01% | 1410 |
|
|
2021
Q2 | – | Sell |
-30,473
| Closed | -$856K | – | 2960 |
|
|
2021
Q1 | $856K | Sell |
30,473
-52,975
| -63% | -$1.49M | 0.01% | 1194 |
|
|
2020
Q4 | $2.17M | Sell |
83,448
-31,715
| -28% | -$823K | 0.02% | 718 |
|
|
2020
Q3 | $1.97M | Sell |
115,163
-44,636
| -28% | -$765K | 0.03% | 629 |
|
|
2020
Q2 | $3.95M | Buy |
+159,799
| New | +$3.95M | 0.06% | 406 |
|
|
2020
Q1 | – | Sell |
-23,911
| Closed | -$242K | – | 2331 |
|
|
2019
Q4 | $242K | Buy |
+23,911
| New | +$242K | ﹤0.01% | 2056 |
|